Wall Street’s mixed close lifts healthcare: top S&P 500 movers plus Abbott probe, 340B drug pricing shift, Medicare GLP-1 access & AZN deal—read now.
Medicare’s new GLP-1 Bridge program boosts seniors’ access to weight-loss drugs through 2027—see top GLP-1 and biotech stocks to watch now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results